摘要:
sci-hub.se 参考文章(4)
ISTVAN ARANY, STEPHEN K. TYRING, Activation of local cell-mediated immunity in interferon-responsive patients with human papillomavirus-associated lesions. Journal of Interferon and Cytokine Research. ,vol. 16, pp. 453- 460 ,(1996) , 10.1089/JIR.1996.16.453
G Gross, A Roussaki, S Baur, M Wiegand, A Mescheder, Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial. Sexually Transmitted Infections. ,vol. 72, pp. 71- 71 ,(1996) , 10.1136/STI.72.1.71
Karl R. Beutner, Spotswood L. Spruance, Andrina J. Hougham, Terry L. Fox, Mary L. Owens, John M. Douglas, Treatment of genital warts with an immune-response modifier (imiquimod) Journal of The American Academy of Dermatology. ,vol. 38, pp. 230- 239 ,(1998) , 10.1016/S0190-9622(98)70243-9
Wallace Dinsmore, Joe Jordan, Colm O'Mahony, John R W Harris, Alexander McMillan, Keith W Radcliffe, Patrick Engrand, Brian W Jackson, Andrew R Galazka, Ayad K Abdul-Ahad, John M Illingworth, Recombinant human interferon- in the treatment of condylomata acuminata International Journal of Std & Aids. ,vol. 8, pp. 622- 628 ,(1997) , 10.1258/0956462971918887